University of Minnesota. Driven to Discover.
Structure details may yield clues on how Zika damages cells and offer an inside track to drug, vaccine, and test developers.
Also, phase 2 trials just launched for two prime-boost Ebola vaccine regimens.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.